Source-Omega announced today it has opened several new pharmaceutical sales accounts this year with their true 50 percent DHA algae oil. The key to their success is expertise in the lipid biochemistry of algae oil, which has helped train the oil to create new trade positions.<\/p>\n
A new algae oil supply was launched two years ago, starting at 35 percent DHA oil and now climbing to 50 percent DHA oil in 2014, all while offing the same price as the 35 percent standard.<\/p>\n
\u201cSOURCE OIL\u2122 continues to brand scientific achievements into 3rd party Intellectual Property. Pharma is able to appreciate a better ingredient product and price will naturally fit into new product developments. Companies want uncut 100% real algae oil, higher omega-3 concentrations and a published omega-3 scientist\u2019s services, not a sales rep. We offer a fresh start for the future, so Pharma CEOs need to be involved for my interest. It goes both ways when finding the right fit,\u201d said Scott Doughman, PhD, CEO and Chief Scientific Officer at Source-Omega.<\/p>\n
The Source-Omega company has a history of innovation in algae oil. Their recent standard carves out exclusive positions they consider more competitive than ever before.<\/p>\n
A trade in algae oil omega-3s has been broadening over the past year with new sources of oil and new products entering the market. Statements of quality certification and production consistency are replacing questions with answers.<\/p>\n